Oleanolic acid attenuates renal fibrosis in mice with unilateral ureteral obstruction via facilitating nuclear translocation of Nrf2

Nutrition and Metabolism

Volumn 11, Issue 1, 2014, Pages

  Chung, Sungjin ^a,b   Yoon, Hye Eun ^a,c   Kim, Soo Jeong ^a   Kim, Sung Jun ^a,c   Koh, Eun Sil ^a,b   Hong, Yu Ah ^e   Park, Cheol Whee ^a,d   Chang, Yoon Sik ^a,b   Shin, Seok Joon ^a,c  

^a The Catholic University of Korea   (South Korea)

^b The Catholic University of Korea   (South Korea)

^c Bupyeong gu   (South Korea)

^d The Catholic University of Korea   (South Korea)

^e Korea University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COLLAGEN; HEAT SHOCK PROTEIN 70; HEME OXYGENASE 1; KELCH LIKE ECH ASSOCIATED PROTEIN 1; LIPID PEROXIDASE; OLEANOLIC ACID; PROTEIN BAX; PROTEIN BCL 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE) 1; TRANSCRIPTION FACTOR NRF2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; ATTENUATION; CELL INFILTRATION; CONTROLLED STUDY; DRUG EFFICACY; INFLAMMATORY CELL; KIDNEY; KIDNEY FIBROSIS; LIPID PEROXIDATION; MALE; MOUSE; NEPHRITIS; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SHAM PROCEDURE; UNILATERAL URETERAL OBSTRUCTION; URETER OBSTRUCTION;

MUS;

EID: 84891514615     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-11-2     Document Type: Article

References (35)

1. Insights into the mechanisms of renal fibrosis: is it possible to achieve regression? Chatziantoniou C, Dussaule JC, Am J Physiol Renal Physiol 2005 289 227 F234 10.1152/ajprenal.00453.2004 16006588 (Pubitemid 41003650)
2. Brief Report: renal replacement therapy in Korea, 2010. Jin DC, Ha IS, Kim NH, Lee SW, Lee JS, Yoon SR, Kim BS, Kidney Res Clin Pract 2012 31 62 71 10.1016/j.krcp.2012.01.005
3. Orchiectomy attenuates kidney fibrosis after ureteral obstruction by reduction of oxidative stress in mice. Cho MH, Jung KJ, Jang HS, Kim JI, Park KM, Am J Nephrol 2012 35 7 16 10.1159/000334598 22143161
4. Biochemical-molecular markers in unilateral ureteral obstruction. Manucha W, Biocell 2007 31 1 12 17665634 (Pubitemid 46797814)
5. Melatonin attenuates unilateral ureteral obstruction-induced renal injury by reducing oxidative stress, iNOS, MAPK, and NF-kB expression. Ozbek E, Ilbey YO, Ozbek M, Simsek A, Cekmen M, Somay A, J Endourol 2009 23 1165 1173 10.1089/end.2009.0035 19530942
6. Oxidative stress in obstructive nephropathy. Dendooven A, Ishola DA Jr, Nguyen TQ, Van der Giezen DM, Kok RJ, Goldschmeding R, Joles JA, Int J Exp Pathol 2011 92 202 210 10.1111/j.1365-2613.2010.00730.x 20804541
7. Obstructive uropathy. Truong LD, Gaber L, Eknoyan G, Contrib Nephrol 2011 169 311 326 21252529
8. Oleanolic acid activates Nrf2 and protects from acetaminophen hepatotoxicity via Nrf2-dependent and Nrf2-independent processes. Reisman SA, Aleksunes LM, Klaassen CD, Biochem Pharmacol 2009 77 1273 1282 10.1016/j.bcp.2008.12.028 19283895
9. Beneficial actions of oleanolic acid in an experimental model of multiple sclerosis: a potential therapeutic role. Martín R, Carvalho-Tavares J, Hernández M, Arnés M, Ruiz-Gutiérrez V, Nieto ML, Biochem Pharmacol 2010 79 198 208 10.1016/j.bcp.2009.08.002 19679109
10. Oleanolic acid prevents glucocorticoid-induced hypertension in rats. Bachhav SS, Patil SD, Bhutada MS, Surana SJ, Phytother Res 2011 25 1435 1439 10.1002/ptr.3431 21953707
11. Antiatherogenic effects of oleanolic acid in apolipoprotein E knockout mice. Buus NH, Hansson NC, Rodriguez-Rodriguez R, Stankevicius E, Andersen MR, Simonsen U, Eur J Pharmacol 2011 670 519 526 10.1016/j.ejphar.2011.09.037 21958874
12. Effects of oleanolic acid on pulmonary morphofunctional and biochemical variables in experimental acute lung injury. Santos RS, Silva PL, Oliveira GP, Cruz FF, Ornellas DS, Morales MM, Fernandes J, Lanzetti M, Valença SS, Pelosi P, Gattass CR, Rocco PR, Respir Physiol Neurobiol 2011 179 129 136 10.1016/j.resp.2011.07.008 21801858
13. The effect of Chinese hepatoprotective medicines on experimental liver injury in mice. Liu J, Liu Y, Klaassen CD, J Ethnopharmacol 1994 42 183 191 10.1016/0378-8741(94)90084-1 7934088 (Pubitemid 24177364)
14. Oleanolic acid protects against cadmium hepatotoxicity by inducing metallothionein. Liu Y, Kreppel H, Liu J, Choudhuri S, Klaassen CD, J Pharmacol Exp Ther 1993 266 400 406 8331568 (Pubitemid 23315675)
15. Role of Nrf2 in prevention of high-fat diet-induced obesity by synthetic triterpenoid CDDO-imidazolide. Shin S, Wakabayashi J, Yates MS, Wakabayashi N, Dolan PM, Aja S, Liby KT, Sporn MB, Yamamoto M, Kensler TW, Eur J Pharmacol 2009 620 138 144 10.1016/j.ejphar.2009.08.022 19698707
16. Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. Kim HJ, Vaziri ND, Am J Physiol Renal Physiol 2010 298 662 F671 10.1152/ajprenal.00421.2009 20007347
17. Urokinase receptor deficiency accelerates renal fibrosis in obstructive nephropathy. Zhang G, Kim H, Cai X, López-Guisa JM, Alpers CE, Liu Y, Carmeliet P, Eddy AA, J Am Soc Nephrol 2003 14 1254 1271 10.1097/01.ASN. 0000064292.37793.FB 12707394 (Pubitemid 36514666)
18. Multifunctionality of PAI-1 in fibrogenesis: evidence from obstructive nephropathy in PAI-1-overexpressing mice. Matsuo S, López-Guisa JM, Cai X, Okamura DM, Alpers CE, Bumgarner RE, Peters MA, Zhang G, Eddy AA, Kidney Int 2005 67 2221 2238 10.1111/j.1523-1755.2005.00327.x 15882265 (Pubitemid 41623383)
19. Predicting renal outcome in IgA nephropathy. Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP, J Am Soc Nephrol 1997 8 199 207 9048338 (Pubitemid 127455874)
20. Orchiectomy attenuates post-ischemic oxidative stress and ischemia/reperfusion injury in mice. A role for manganese superoxide dismutase. Kim J, Kil IS, Seok YM, Yang ES, Kim DK, Lim DG, Park JW, Bonventre JV, Park KM, J Biol Chem 2006 281 20349 20356 10.1074/jbc.M512740200 16682413 (Pubitemid 44065809)
21. Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis. Kramer AB, van der Meulen EF, Hamming I, Van Goor H, Navis G, Kidney Int 2007 71 417 424 10.1038/sj.ki.5002075 17213874
22. Oxidative stress and dysregulation of superoxide dismutase and NADPH oxidase in renal insufficiency. Vaziri ND, Dicus M, Ho ND, Boroujerdi-Rad L, Sindhu RK, Kidney Int 2003 63 179 185 10.1046/j.1523-1755.2003.00702.x 12472781 (Pubitemid 35463919)
23. Renal response during acute unilateral ureteral obstruction in rats. Chen CF, Yeh SU, Chien CT, Wu MS, Neurourol Urodyn 2001 20 125 137 10.1002/1520-6777(2001)20:1<125::AID-NAU14>3.0.CO;2-Y 11135389 (Pubitemid 32096334)
24. Interspecies scaling of oleanolic acid in mice, rats, rabbits and dogs and prediction of human pharmacokinetics. Ji HY, Shin BS, Jeong DW, Park EJ, Park ES, Yoo SD, Lee HS, Arch Pharm Res 2009 32 251 257 10.1007/s12272-009-1230- 1 19280156
25. Anti-glycative effects of oleanolic acid and ursolic acid in kidney of diabetic mice. Wang ZH, Hsu CC, Huang CN, Yin MC, Eur J Pharmacol 2010 628 255 260 10.1016/j.ejphar.2009.11.019 19917277
26. Oleanolic Acid, a plant triterpenoid, significantly improves survival and function of islet allograft. Nataraju A, Saini D, Ramachandran S, Benshoff N, Liu W, Chapman W, Mohanakumar T, Transplantation 2009 88 987 994 10.1097/TP.0b013e3181b9cbc4 19855244
27. Role of haeme oxygenase-1 in resolution of oxidative stress-related pathologies: focus on cardiovascular, lung, neurological and kidney disorders. Haines DD, Lekli I, Teissier P, Bak I, Tosaki A, Acta Physiol (Oxf) 2012 204 487 501 10.1111/j.1748-1716.2011.02387.x 22118298
28. Nrf2-dependent and Nrf2-independent induction of phase 2 detoxifying and antioxidant enzymes during keratinocyte differentiation. Piao MS, Park JJ, Choi JY, Lee DH, Yun SJ, Lee JB, Lee SC, Arch Dermatol Res 2012 304 387 395 10.1007/s00403-012-1215-7 22310733
29. eNOS/Hsp70 interaction on rosuvastatin cytoprotective effect in neonatal obstructive nephropathy. Manucha W, Kurbán F, Mazzei L, Benardón ME, Bocanegra V, Tosi MR, Vallés P, Eur J Pharmacol 2011 650 487 495 10.1016/j.ejphar.2010.09.059 20940012
30. The heme oxygenase-1 protein is overexpressed in human renal cancer cells following activation of the Ras-Raf-ERK pathway and mediates anti-apoptotic signal. Banerjee P, Basu A, Datta D, Gasser M, Waaga-Gasser AM, Pal S, J Biol Chem 2011 286 33580 33590 10.1074/jbc.M111.248401 21808062
31. Inhibitor of Nrf2 (INrf2 or Keap1) protein degrades Bcl-xL via phosphoglycerate mutase 5 and controls cellular apoptosis. Niture SK, Jaiswal AK, J Biol Chem 2011 286 44542 44556 10.1074/jbc.M111.275073 22072718
32. Alpha-lipoic acid upregulates antioxidant enzyme gene expression and enzymatic activity in diabetic rat kidneys through an O-GlcNAc-dependent mechanism. Arambašić J, Mihailović M, Uskoković A, Dinić S, Grdović N, Marković J, Poznanović G, Bajec D, Vidaković M, Eur J Nutr 2013 52 1461 1473 10.1007/s00394-012-0452-z 23064900
33. Ulinastatin inhibits unilateral ureteral obstruction-induced renal interstitial fibrosis in rats via transforming growth factor β (TGF-β)/Smad signalling pathways. Ning XH, Ge XF, Cui Y, An HX, Int Immunopharmacol 2013 15 406 413 10.1016/j.intimp.2012.12.019 23318600
34. A reduction of unilateral ureteral obstruction-induced renal fibrosis by a therapy combining valsartan with aliskiren. Wu WP, Chang CH, Chiu YT, Ku CL, Wen MC, Shu KH, Wu MJ, Am J Physiol Renal Physiol 2010 299 929 F941 10.1152/ajprenal.00192.2010 20685818
35. Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated mice. Yates MS, Tran QT, Dolan PM, Osburn WO, Shin S, McCulloch CC, Silkworth JB, Taguchi K, Yamamoto M, Williams CR, Liby KT, Sporn MB, Sutter TR, Kensler TW, Carcinogenesis 2009 30 1024 1031 10.1093/carcin/ bgp100 19386581